Anticoagulant Therapy in nstemi patients

Curriculum Vitae

? Name : Prof. DR. Dr. Idrus Alwi SpPD, K-KV, FACC, FESC, FAPSIC, FINASIM, FACP.

? Current Position : Professor of Internal Medicine, Faculty of Medicine, University of Indonesia.

? Medical Student : Faculty of Medicine University of Indonesia 1986 ? Internist : Faculty of Medicine University of Indonesia 1996 ? Cardiovascular Consultant : The Indonesian Society of Internal Medicine , 2001 ? PhD : Faculty of Medicine University of Indonesia, 2006 ? FACC : American College of Cardiology, 2006 ? FESC : European Society of Cardiology, 2008 ? FAPSIC : Asia Pacific Society of Interventional Cardiology, 2009 ? FINASIM : Indonesian Society of Internal Medicine, 2009 ? FACP : American Colleague of Physician, 2013 ? Advanced Course in Cardiology, Melbourne 1997 ? Advanced Course on Echocardiography and Others Non Invasive Cardiology, Melbourne 1997 ? Stem cell NOGA course, Cincinnatti, Ohio, 2009 ? ASAN Interventional Cardiology Course, Seoul, 2011

The Role of Anticoagulant in ACS Management

Prof. Idrus Alwi MD, PhD, FINASIM, FACP, FACC, FESC, FAPSIC Division of Cardiology, Department of Internal Medicine, Faculty of Medicine , University of Indonesia, Jakarta , Indonesia

Outline

Spectrum of ACS, Therapy, Risk Stratification, Target of Anticoagulant

OASIS 5, Registry Data, OASIS 8

Recommendation of Anticoagulants

Conclusion

Outline

Spectrum of ACS, Therapy, Risk Stratification, Target of Anticoagulant

OASIS 5, Registry Data, OASIS 8

Recommendation of Anticoagulants

Conclusion

The spectrum of ACS

European Heart Journal (2011) 32, 2999?3054

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download